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The molecular genetics of the autosomal recessive disorder pycnodysostosis was studied in five
independent families from an outbred Caucasian population. We found two new mutations and one
recently described mutation in the cathepsin K gene by sequencing DNA from eight patients with
pycnodysostosis: a one base transition in exon 8, c926T > C, causing a single amino acid substitution
leucine ® proline, L309P; A 3' splice site mutation in intron 2, c121–1G > A, causing deletion of all exon 3,
41V–81Mdel; and the exon 3 missense mutation c236G > A leading to residue G79E. In three of the
families patients were homozygous for 926T > C. In the remaining two families patients were
heterozygous for 926T > C and 121–1G > A in one case, and for 926T > C and 236G > A in the other case.
Assays using genomic DNA were developed for all three mutations. We tested 150 healthy control persons
and observed the mutation frequencies: 0 to 300 for 121–1G > A and 236G > A and 1 to 150 for 926T > C.
One patient from each family was haplotyped with eight microsatellite markers surrounding the cathepsin
K gene on chromosome 1q21. A very rare, P = 1.8 3 10–6 to P = 0.0004, and highly preserved area around
the presumed disease locus was common to all the patients. This haplotype was found on seven
chromosomes identical by state, IBS, out of the possible eight carrying the 926T > C mutation. Founder
effect, locus homogeneity, and allele heterogeneity regarding pycnodysostosis within this population are
discussed. Finally, the first pregnancy and delivery described in a patient with pycnodysostosis is reported.
European Journal of Human Genetics (2000) 8, 431–436.
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Introduction
Pycnodysostosis (MIM No. 265800) is a rare autosomal
recessive disorder characterised by short stature, delayed
closure of the cranial sutures, loss of the mandibular angle,
dysplastic terminal phalanges of the hands and feet, and
increased bone fragility. The disorder was first described in
1962.1,2
The gene for pycnodysostosis has been mapped to chromo-
some 1q21 independently by two groups3,4 to a 6 and 4cM
interval, respectively, and later narrowed down to a 2cM
region.5 Mutations in the cathepsin K gene (NCBI Unigene
No. U13665), a cystein protease gene highly expressed in
osteoclasts, have been found to be responsible for pycnody-
sostosis. Three intragenic mutations were reported6,7 in three
large inbred families with Moroccan Arab, American His-
panic and Israeli Arab ethnic backgrounds, respectively.
Three mutations were found in two non-consanguineous
families of different ethnic origin.8,9 Another seven muta-
tions were described in nine unrelated families.10,11
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To focus on the question of locus heterogeneity and allele
heterogeneity within the same population we here present a
study of mutations and haplotypes in eight patients from five
independent families with pycnodysostosis in an outbred
Caucasian population.
Material and methods
Patients
A total of nine patients with pycnodysostosis was admitted to
either the paediatric or the orthopaedic department at
Herning Central Hospital over a period of 46 years mainly
due to neonatal respiratory problems, retarded growth,
dysmorphic features, or frequent and complicated bone
fractures. Eight of the patients and six of their parents wished
to participate in the study (Figure 1). The age of the patients
ranged from 3 to 50 years. The control panels consisted of
50 healthy Danish females (panel A) and 100 healthy Danish
adults, sex ratio 0.5, (panel B), respectively. The size of the
population in the county served by Herning Central Hospital
was 271 855. All the controls were collected in the western
part of Denmark from a total population of 2.9 million.
The local ethical committee has approved the project, and
the participants have given informed consent.
After we ended the study one of the pycnodysostosis
patient (II:9) gave birth to a healthy girl born after an
uncomplicated pregnancy. An elective Caesarean was per-
formed three weeks prior to the estimated due day, to prevent
complications during labour. The birth weight was 2500 g.
Neither the healthy father nor his daughter have yet been
tested for pycnodysostosis haplotypes or mutations. Preg-
nancy and delivery among patients with pycnodysostosis
have not previously been described in the literature.
DNA sequencing
Total RNA was made from EBV transformed lymphocyte
cultures. For cDNA synthesis 200 ng RNA was used in the
Titan™ One Tube RT-PCR System (Boehringer Mannheim,
http://biochem.boehringer-mannheim.com) in a total vol-
ume of 50 íl. The primers were the external set of primers
used by Gelb et al.6 Then nested priming was performed with
1 íl RT-PCR product in a total PCR mix of 50 íl using the
internal primer set6 to amplify a 1129 bp fragment of the
cathepsin K gene. After using High Pure PCR Product
Purification Kit (Boehringer Mannheim, http://biochem
.boehringer-mannheim.com) the internal set of primers was
used again for the first cycle sequence preparation (ABI Prism
Dye Terminator Cycle Sequencing Ready Reaction Kit, Per-
kin-Elmer). The samples were precipitated with ethanol and
sodium acetate. Sequence analysis with a ABI Prism 377
(Perkin-Elmer, Langen, Germany) was successful only in the
antisense direction. This might be explained by divergence of
the forward primer in the two terminal base pairs from the
wildtype base sequence (NCBI Unigene accession U13665).
The correct nested sense primer should be
5'-CCCCTGATGGTGTGCCCAC-3'. To overcome this prob-
lem we designed another set of internal primers for a second
Figure 1 Pedigrees of the five pycnodysostosis families.
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sequence analysis of the cDNA. The primers were 5'-GAAAG-
GATATGTTACTCCTG-3' (sense) and 5'-AGCCCAACAG-
GAACCACACT-3' (antisense).
Mutation analysis
The 121–1G > A mutation assay was based on a 187 bp PCR
fragment from amplification of gDNA with the primers:
5'-CCTTTATGATTGTGAGTTTCC-3' (sense) located in
intron 2 and 5'-TGTATGGACACCAAGAGAAG-3' (antisense)
located in exon 3. The amplifications were performed in a
Biometra Personal Cycler and 9 ng DNA was used in a total
PCR mix of 6 íl. The PCR conditions were: 1 cycle of 94°C for
5 min, 55°C for 30 s, and 72°C for 36 s; 26 cycles of 94°C for
30 s, 55°C for 30 s, and 72°C for 36 s; 1 cycle of 94°C for 30 s,
55°C for 30 s, and 72°C for 10 min. Fragments of 119 bp ,
94 bp, 68 bp, and 25 bp were separated in a 4% NuSieve gel
after incubating 10 íl PCR product with 5 units Tru9I restric-
tion enzyme overnight at 37°C. In this assay the 68 bp
fragment was common to all the individuals due to a second
and constant Tru9I restriction site (Figure 3).
The 236G > A mutation was tested by amplifying cDNA
with the primers 5'-TGGGAGCTATGGAAGAAGA-3' (sense)
and 5'-GTAACATATCCTTTCTTTCG-3' (antisense). Annealing
temperature was 51°C and the remaining PCR conditions as
described above. A 308 bp PCR fragment was digested with
MnlI for 12 h at 37°C. Gel electrophoreses showed bands of
138, 104, 66 and 49 bp. Amplification of gDNA gave a 857 bp
PCR fragment and a mutation band of approximately 100 bp
(Figure 3). The accurate band length could not be determined
due to unknown restriction sites in introns 2 and 3.
To test for the 926 > C mutation a PCR fragment of 523 bp
was amplified from gDNA using the primers 5'-CTGGGGA-
GAAAACTGGGGAA-3' (sense) and 5'-CCTTGAGGATATT-
GAAGGGAACTTAG-3' (antisense). The latter was identical to
the first reverse primer used in the nested priming. The PCR
conditions were as earlier described. After incubating 10 íl
PCR product overnight at 37°C with 5 unit restriction
enzyme MnlI the fragments (523 bp, 480 bp and 43 bp) were
separated in a 4% NuSieve gel (Figure 3). An extra MnlI
restriction site was expected in the 523 bp fragment from
viewing the wildtype sequence, but sequencing the area
showed a divergence from the database in about posi-
tion 1171 where the nucleotide was A instead of T.
Haplotyping
DNA was extracted from 10 ml EDTA peripheral blood by the
simple salting out procedure.12,18 In total eight microsatellite
markers were labelled radioactive with [33P]-çATP. The primer
sequences and the genetic distances were obtained from GDB
(http://gdbwww.gdb.org/) and from Marshfield (http:/
/www.marshmed.org/genetics/), respectively. PCR conditions
were as described under the mutation analysis. For D1S303
the annealing temperature was 60°C. Formamide-based dye
was added followed by denaturation at 94°C for 5 min.
Electrophoresis was performed in a 6% polyacrylamide gel
with 7 M urea and run for 2 h at 60 W. The gel was dried and
exposed to X-ray films for 1–5 days. Two persons scored the
marker alleles independently. The estimated haplotype fre-
quencies in the population were calculated by multiplying
the individual marker allele frequencies obtained from the
CEPH database (http://www.cephb.fr/).
Results
Eight pycnodysostosis patients from five Danish families
containing three sib pairs with the disease were included. A
full medical and family history was obtained from each
patient. Clinical photos and X-rays of the cranium, man-
dibular angle and left hand were taken to document the
diagnosis. Blood for chromosomal analysis, DNA extraction
and lymphocyte culturing were sampled. The eight patients
Figure 2 Genomic structure of the human cathepsin K gene (12) showing the localisation of the three mutations and 121–1G > A,
236G > A and 926T > C.
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represented five nuclear families (Figure 1), that could not be
related four generations back. The pedigrees revealed no
consanguinity. Three of the patients have previously been
described clinically, patients no. II:7, II:11 and II:18.13 No
chromosomal abnormalities were detected in the patients.
EBV transformed lymphocyte cultures were obtained from
5 patients (II:2, II:7, II:8, II:9, and II:11) and cathepsin K gene
cDNA was made from mRNA. Sequencing the gene in the five
patients revealed three different mutations:
1. a major deletion of 123 bp from cDNA nucleotide
position 121 to 243 predicting a loss of 41 amino acids
in the cathepsin K polypeptide, 41V–81Mdel;
2. a one base G ® A transition in cDNA nucleotide
position 236 changing a glycine to a glutamine residue,
G79E;
3. a one base T ® C transition in cDNA nucleotide
position 926 predicting a substitution of a leucine to a
proline at residue 309 in the mature peptide, L309P.
The 236G > A mutation was described recently.10,11 By
viewing the described structure of the human cathepsin K
gene14 the 123 bp deletion turned out to be a full deletion of
exon 3, and the one base substitution at about 926T > C
occurred in exon 8 within the coding region (Figure 2). The
exon 3 deletion was further investigated by PCR amplifica-
tion from genomic DNA of a 925 bp fragment covering all
exon 3 and intron 2 and 3. Sequencing showed a splice site
mutation in the last nucleotide position in intron 2, about
121–1G > A, to be responsible for the total exon 3 skipping.
Predictions of the secondary protein structure by an IBCP-
Web server analysis15,16 showed the 926T > C mutation to
result in limitation of a beta-sheet domain and the
121–1G > A mutation to alter a large domain of both coils
and helixes to a small domain of only coils.
RFLP based assays were designed for all three mutations,
and patients and parents were tested. This confirmed segrega-
tion of the mutations with the disease in the families
(Figure 3). The three mutations were tested in two independ-
ent panels of healthy adults from the Danish population –
consisting of 50 (panel A) and 100 (panel B) persons,
respectively. Two persons from panel A turned out to be
heterozygous for 926T > C, whilst none from panel B carried
the mutation giving a frequency of 1:150. The two hetero-
zygous controls were also sequenced with respect to exon 8,
which confirmed that they did carry the 926T > C mutation.
Neither 121–1G > A nor 236G > A was found in any of the
150 controls.
We used eight Gene´thon microsatellite markers from
chromosome 1q21 surrounding the cathepsin K gene to
determine the haplotypes (Figure 4). The parents were haplo-
typed so as to recognise the phase when necessary and
possible. Three out of eight chromosomes carrying the
mutation 926T > C also carried an extended haplotype, a
master haplotype, of approximately 9 cM. Assuming linkage
equilibrium the frequency of the master haplotype was
estimated, P = 1.8 3 10–6. Seven out of eight chromosomes
carried preserved pieces of varying length of the master
haplotype. The longest piece of haplotype common to all
seven chromosomes, the core haplotype, was characterised by
markers D1S442, D1S498 and D1S2345, P = 0.004. Observing
this rare core haplotype seven out of eight times strongly
indicated a founder effect. One chromosome in patient II:2
did not have the core haplotype despite carrying the
common mutation 926T > C.
Figure 3 The three RFLP mutation assays showing the use of the restriction enzymes (MnlI, Tru9I), fragment length in base pair (bp)
and segregation of the disease alleles* in the families (1–5). The fragment lengths of mutation assay 236G > A are approximate.
Genomic DNA was amplified.
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Discussion
Pycnodysostosis is a potentially life-threatening genetic
disease due to respiratory problems in early infancy. It can be
physically invalidating due to multiple complicated bone
fractures and may be psychologically devastating due to
social isolation and discrimination because of dwarfish
height and some very characteristic dysmorphic features, this
is in spite of the patients having normal intelligence and
often being very well educated.
The advance of knowledge of the pathophysiology of
pycnodysostosis will help the patients and their families and
may also push forward the work in other related and much
more common diseases. The pycnodysostosis candidate gene
cathepsin K, CTSK, contributes significantly to the enzymatic
activity that has been ascribed to cysteine class proteases,
which are implicated in degradation of the protein compo-
nents within bone during the resorptive stage of organ
remodelling.17 Kinetic and biochemical studies indicate that
cathepsin K is intimately involved in the process of bone
resorption. Thus it represents a new molecular target in
treatment of diseases associated with excessive bone loss –
such as osteoporosis.
We have sampled small and primarily unrelated families
with pycnodysostosis to look for locus and allele heterogene-
ity in this disease.
The mutation study reveals two novel mutations
121–1G > A and 926T > C, and one known mutation,
236G > A, in the CTSK gene. Our prediction of the secondary
protein structure of 121–1G > A and 926T > C supports an
expectation of the two mutations being functional. Also the
cathepsin K nucleotide and amino acid sequence is highly
conserved among species. The leucine at residue 309 in
exon 8 is alike in human, mouse, rabbit, and chicken, and the
human amino acid sequence in exon 3 is 97%, 95% and 76%
identical to rabbit, mouse and chicken, respectively.18 This
indicates that these mutations are likely to cause disease. The
926T > C mutation is common to all our patients and its
frequency in the Danish control population is 0.007 (95% CI:
0.0008–0.0227). Regarding this mutation only, it corresponds
to a disease prevalence of 1:22500 (95% CI: from 1: 1.6 3 106
to 1:1940), since there is no tradition of consanguineous
marriages in the Danish population. The 121–1G > A and
236G > A mutations respectively are only found in one of the
five families. Their frequencies within the population can not
be calculated but are predicted to be below 1:300.
The haplotype study finds a rare and highly preserved area,
the core haplotype, on chromosome 1q similar for all the
patients. A possible common founder in the population
studied would explain the very high occurrence of the master
haplotype, although in different variations, in the five
nuclear families. The means of introduction could either be
by a new mutation or by immigration from another popula-
tion of a person carrying the mutation. The latter cause
would predict the mutation to exist in an older form in
another population. Thus, we hypothesise that the eight
pycnodysostosis patients in our study are related to a
common ancestor. Patient II:2 is heterozygous for the core
haplotype although homozygous for the 926T > C mutation.
This can be explained in two different ways, either the same
mutation happened twice in two different chromosomes, or
the mutation happened only in one chromosome and the
haplotype was changed by crossing over during segregation.
The second explanation would suggest the non-core haplo-
type chromosome in II:2 is much more distantly related than
the other seven core-haplotype chromosomes. Our results
confirm the disease locus previously reported6–11 and show
that at least three mutations exist in the Danish population.
Consequently, this study indicates locus homogeneity and
allele heterogeneity in pycnodysostosis within an outbred
population. Further more we demonstrate a strong founder
effect for pycnodysostosis in Herning County.
Testing more patients with pycnodysostosis will help to
estimate a more precise frequency of already found muta-
tions and reveal still unknown ones. Such knowledge will
make it possible to test for carrier status in the population
and lead to a much more accurate calculation of the
mutation frequencies. Attempts to design specific treatment
for pycnodysostosis and other diseases with excessive bone
loss may benefit from these new results.
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